YMAB - Balance Sheet - Y-mAbs Therapeutics, Inc.

Current Liabilities	23.7 M
Accounts Payable	6.66 M
Short-Term Debt	630 K
Other Current Liabilities	16.4 M
Non-Current Liabilities	4.2 M
Long-Term Debt	190 K
Other Non-Current Liabilities	4.01 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	67.2	78.6	105.8	181.6	114.6	207.1	147.8	90.5	16.9
Short Term Investments	0	0	0	0	0	0	0	0	0
Receivables	19.7	22.5	12.5	7.7	0	0	0	0	0
Inventory	7.2	5.1	6.7	5.5	(0.8)	0	0	0	0
Other Current Assets	4.4	5.0	5.5	7.5	7.7	4.8	3.7	0.9	0.4
Total Current Assets	98.5	111.1	130.4	202.3	122.4	212.0	151.5	91.4	17.3
PP&E	0.9	1.6	2.3	5.7	6.4	4.0	0.2	0	0
Intangible Assets	2.3	2.6	3.0	1.7	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0
Other Long Term Assets	18.3	12.5	5.7	3.2	3.3	0.4	0.2	0.8	0
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	119.9	127.9	141.5	212.8	132.0	216.4	151.9	92.1	17.3
LIABILITIES
Accounts Payable	6.7	6.1	14.2	13.6	9.4	8.5	5.9	5.9	2.2
Short Term Debt	0.6	0.9	1.7	3.6	3.9	1.0	0	0	0
Other Current Liabilities	16.4	13.2	12.4	10.8	6.2	4.0	3.3	2.0	0.7
Total Current Liabilities	23.7	20.1	28.3	27.9	19.5	13.6	9.1	7.9	3.0
Long Term Debt	0.2	0.5	0.9	1.9	2.0	1.7	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0
Other Liabilities	4.0	6.2	3.1	3.0	4.7	2.2	2.3	2.0	2.2
Total Liabilities	27.9	26.9	32.2	32.7	26.2	17.5	11.4	10.0	5.2
EQUITY
Common Stock	4 K	4 K	4 K	4 K	4 K	4 K	3 K	3 K	2 K
Retained Earnings	(487.1)	(457.5)	(436.0)	(340.5)	(285.2)	(165.9)	(84.8)	(41.6)	(22.4)
Other Accumulative Comprehensive Income/Loss	2.3	0.4	1.3	1.4	(0.5)	50 K	7 K	(0.2)	30 K
Total Equity	92.0	101.0	109.2	180.1	105.8	198.9	140.5	82.2	12.1
Total Liabilities and Equity	119.9	127.9	141.5	212.8	132.0	216.4	151.9	92.1	17.3
SHARES OUTSTANDING
Common Shares Outstanding	44.3	43.6	43.7	43.2	40.1	35.2	28.8	33.3	33.3

Free